COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of
patients with heart failure (HF). Several consensus documents describe the appropriate …

Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

Acute heart failure (AHF) is the most frequent cause of unplanned hospital admission in
patients of> 65 years of age and it is associated with significantly increased morbidity …

Background Patients with heart failure (HF) are at high risk for adverse outcomes when they
have COVID-19. Reports of COVID-19 vaccine-related cardiac complications may contribute …

BACKGROUND: Patients with heart failure are vulnerable to the SARS-CoV-2 infection.
However, limited evidence exists on the safety of the SARS-CoV-2 mRNA vaccines in this …

Background Patients with cardiorespiratory problems often suffer from systemic
inflammation. Stress due to the disease and continuous inflammation can undermine the …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

The COVID-19 pandemic has particularly affected older adults residing in nursing homes,
resulting in high rates of hospitalisation and death. Here, we evaluated the longitudinal …

Heart failure exacerbations impart significant morbidity and mortality, however, large-scale
studies assessing outcomes in the setting of concurrent coronavirus disease-19 (COVID-19) …